Utilization of drugs with pregnancy exposure registries during pregnancy
Pharmacoepidemiology and Drug Safety2018Vol. 27(6), pp. 604–611
Citations Over TimeTop 15% of 2018 papers
Onyekachukwu A. Illoh, Sengwee Toh, Susan E. Andrade, Christian Hampp, Leyla Şahin, Kate Gelperin, Lockwood G. Taylor, Steven T. Bird
Abstract
Among drugs with pregnancy exposure registries, use was less during pregnancy compared with before pregnancy and to the matched nonpregnant episodes. The lower utilization during pregnancy suggests that women may be avoiding these drugs to minimize potentially harmful exposure during pregnancy. This lower utilization may increase the challenges of further studying the safety of these drugs using pregnancy exposure registries.
Related Papers
- → Efficacy and safety of lung recruitment in pediatric patients with acute lung injury(2010)56 cited
- → Hemoglobin Levels Across the Pediatric Critical Care Spectrum: A Point Prevalence Study*(2018)8 cited
- → Prognostic value of proadrenomedullin in patients with COVID-19 pneumonia(2022)3 cited
- [Health-related quality of life by IBDQ-32 in colombian patients with inflammatory bowel disease in remission: A cross-sectional study].(2023)
- 效果热门在有干燥眼睛疾病的病人的角膜的内皮细胞层上的 0.05% cyclosporine A(2013)